[HTML][HTML] Denosumab in postmenopausal women with low bone mineral density
…, CH Chesnut, D Lain, AJ Kivitz… - … England Journal of …, 2006 - Mass Medical Soc
Background Receptor activator of nuclear factor-κB ligand (RANKL) is essential for osteoclast
differentiation, activation, and survival. The fully human monoclonal antibody denosumab (…
differentiation, activation, and survival. The fully human monoclonal antibody denosumab (…
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression
PJ Mease, AJ Kivitz, FX Burch, EL Siegel… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Etanercept has been shown to improve the articular and cutaneous manifestations
of psoriatic arthritis (PsA). In this study, we further evaluated the safety, efficacy, and effect …
of psoriatic arthritis (PsA). In this study, we further evaluated the safety, efficacy, and effect …
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial
LS Simon, AL Weaver, DY Graham, AJ Kivitz… - Jama, 1999 - jamanetwork.com
ContextIn vitro studies have shown that celecoxib inhibits cyclooxygenase 2 (COX-2) but not
COX-1, suggesting that this drug may have anti-inflammatory and analgesic activity without …
COX-1, suggesting that this drug may have anti-inflammatory and analgesic activity without …
Efficacy and safety of rilonacept (interleukin‐1 Trap) in patients with cryopyrin‐associated periodic syndromes: results from two sequential placebo‐controlled studies
…, ML Throne, NJ Amar, M Sebai, AJ Kivitz… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To assess the efficacy and safety of rilonacept (Interleukin‐1 [IL‐1] Trap), a long‐acting
and potent inhibitor of IL‐1, in patients with cryopyrin‐associated periodic syndromes (…
and potent inhibitor of IL‐1, in patients with cryopyrin‐associated periodic syndromes (…
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double‐blind, placebo‐controlled study
…, T Conrozier, D Loeuille, AJ Kivitz… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To evaluate the clinical response, safety, and tolerability of a single intraarticular
injection of anakinra in patients with symptomatic osteoarthritis (OA) of the knee. Methods …
injection of anakinra in patients with symptomatic osteoarthritis (OA) of the knee. Methods …
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a …
R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots… - The Lancet, 2017 - thelancet.com
Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the comparative …
arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the comparative …
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week …
…, YH Huang, R Jajoo, NM Janssen, U Kiltz, AJ Kivitz… - The Lancet, 2017 - thelancet.com
Background Patients who have had inadequate response to tumour necrosis factor inhibitors
have fewer treatment options and are generally more treatment refractory to subsequent …
have fewer treatment options and are generally more treatment refractory to subsequent …
Abatacept in the treatment of patients with psoriatic arthritis: results of a six‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II trial
…, MC Genovese, G Gladstein, AJ Kivitz… - Arthritis & …, 2011 - Wiley Online Library
Objective To assess the safety and efficacy of abatacept, a selective T cell costimulation
modulator, in patients with psoriatic arthritis (PsA). Methods In this 6‐month, multicenter, …
modulator, in patients with psoriatic arthritis (PsA). Methods In this 6‐month, multicenter, …
[PDF][PDF] Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a phase III study
MC Genovese, R Fleischmann, AJ Kivitz… - Arthritis & …, 2015 - Wiley Online Library
… Genovese,1 Roy Fleischmann,2 Alan J. Kivitz,3 Maria Rell-Bakalarska,4 Renata Martincova,5
Stefano Fiore,6 Patricia Rohane,6 Hubert van Hoogstraten,6 … Kivitz has been a clinical …
Stefano Fiore,6 Patricia Rohane,6 Hubert van Hoogstraten,6 … Kivitz has been a clinical …
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
JL Kaine, AJ Kivitz, C Birbara, AY Luo - The Journal of rheumatology, 2007 - jrheum.org
OBJECTIVE: This study compared the immunogenicity of influenza and pneumococcal
vaccines in adult patients with rheumatoid arthritis (RA) receiving adalimumab or placebo. …
vaccines in adult patients with rheumatoid arthritis (RA) receiving adalimumab or placebo. …